Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00587106 · ClinicalTrials.gov registry record
Studies of Neurological Paraneoplastic Syndromes
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 51
- Enrollment target
NCT00587106: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00587106 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 51 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00587106 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 51 participants
- Enrollment target
Study Summary
This study is for patients with cancer, a known paraneoplastic syndrome, or neurological problems that suggest a paraneoplastic syndrome.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 1988-04 |
| Est. Completion | 2009-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00587106
The ClinicalTrials.gov registry entry for NCT00587106 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00587106 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00587106 about?
NCT00587106 is a clinical study titled "Studies of Neurological Paraneoplastic Syndromes". This study is for patients with cancer, a known paraneoplastic syndrome, or neurological problems that suggest a paraneoplastic syndrome.
What is the current status of trial NCT00587106?
This trial is currently completed. The enrollment target is 51 participants. The study started on 1988-04. Estimated completion is 2009-03.
Who is sponsoring clinical trial NCT00587106?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.